chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Headache; Myalgia; Chills; Lymphadenopathy; Brain fog; This is a spontaneous report from a contactable physician (patient). A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Ek9231) via intramuscular in left arm on 02Jan2021 18:00 at single dose for COVID 19 immunization. The patient received the vaccine in hospital. Medical history included asthma, migraine. Known allergies included Latex allergy. Concomitant medication included oral contraceptive pill (OCP), ergocalciferol (VIT D), melatonin, ubidecarenone (COQ10) and fexofenadine hydrochloride (ALLEGRA). No other vaccine was received in four weeks. The patient didn't have COVID prior vaccination.  The patient experienced headache, brain fog, myalgia, chills, lymphadenopathy on 03Jan2021. Therapeutic measures were taken as a result of events including ibuprofen (MOTRIN). The events did not require Emergency Room Visit or Physician Office Visit. No COVID was test post vaccination. The outcome of events was recovered in Jan2021.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: I felt dizzy; nauseated; This is a spontaneous report from a non-contactable consumer (patient). This 65-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EL9261), via an unspecified route of administration on 20Jan2021 14:15 at single dose on the right arm for COVID-19 immunization. The patient medical history was none. No known allergies. The patient's concomitant medications were not reported. No other vaccine received in four weeks. Within 15 mins of being vaccinated, patient felt dizzy and nauseated. Patient believed these symptoms would have been less severe had she eaten something and drunk sufficient fluids prior to the injection. The symptoms went away within a couple of hours after eating and drinking. No COVID prior vaccination. No COVID tested post vaccination. No treatment received. Outcome of the events was recovered in Jan2021.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fatigue, Headache, Muscle spasms
Clinical narrative: Charlie horses in legs; multiple cold sores on lip; Chills; Fatigue; headache; cold sweats; This is a spontaneous report from a contactable nurse (patient herself). A 59-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unable to locate or read the details), via an unspecified route of administration on 19Jan2021 13:00 at single dose in right arm for COVID-19 immunization. Medical history included psoriasis, high blood pressure, thyroid removal. The patient had no Known allergies. The patient other concomitant medications in two weeks included guselkumab (TREMFYA), levothyroxine sodium (SYNTHROID), aspirin (acetylsalicylic acid), bupropion hydrochloride (WELLBUTRIN), nebivolol hydrochloride (BYSTOLIC). Prior vaccination, the patient had not had COVID, not tested post vaccination. No other vaccine in four weeks. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 19Dec2020 at 12:00 PM at single dose in right arm for COVID-19 immunization. The patient experienced charlie horses in legs, multiple cold sores on lip, chills, fatigue, headache, cold sweats on 20Jan2021 07:00. The patient did not received treatment for events. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 22Jan2021.  The outcome of the events charlie horses in legs, multiple cold sores on lip, chills, fatigue, headache, cold sweat was recovered in Jan2021.   Information on the Lot/Batch number has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes, SARS-CoV-2 test
Clinical narrative: Charlie horses in legs; multiple cold sores on lip; Chills; Fatigue; headache; cold sweats; This is a spontaneous report from a contactable nurse (patient herself). A 59-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unable to locate or read the details), via an unspecified route of administration on 19Jan2021 13:00 at single dose in right arm for COVID-19 immunization. Medical history included psoriasis, high blood pressure, thyroid removal. The patient had no Known allergies. The patient other concomitant medications in two weeks included guselkumab (TREMFYA), levothyroxine sodium (SYNTHROID), aspirin (acetylsalicylic acid), bupropion hydrochloride (WELLBUTRIN), nebivolol hydrochloride (BYSTOLIC). Prior vaccination, the patient had not had COVID, not tested post vaccination. No other vaccine in four weeks. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 19Dec2020 at 12:00 PM at single dose in right arm for COVID-19 immunization. The patient experienced charlie horses in legs, multiple cold sores on lip, chills, fatigue, headache, cold sweats on 20Jan2021 07:00. The patient did not received treatment for events. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 22Jan2021.  The outcome of the events charlie horses in legs, multiple cold sores on lip, chills, fatigue, headache, cold sweat was recovered in Jan2021.   Information on the Lot/Batch number has been requested.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Aphthous ulcer
Clinical narrative: Aphthous Ulcer; This is a spontaneous report from a contactable physician for himself. A 29-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EC4248), via an unspecified route of administration on left arm on 19Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history reported as none.  The patient's concomitant medications were not reported.  The patient previously took aspirin [acetylsalicylic acid] and experienced drug hypersensitivity. The patient took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on left arm on 29Dec2020 02:45 PM at single dose for covid-19 immunisation. The patient experienced aphthous ulcer on 21Jan2021 12:00 with outcome of not recovered. No treatment received. No Covid prior vaccination. No Covid tested post vaccination.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Vomiting
Clinical narrative: Fever; Headache; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. This 72-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: Unknown), via an unspecified route of administration on 15Jan2021 (at the age of 72-years-old) as a single dose for COVID-19 vaccination. The patient's medical history was not reported. There were no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. On 20Jan2021, the patient experienced fever, headache and vomiting 5 days after vaccination. No therapeutic measures were taken as a result of the events. The clinical outcomes of the fever, headache and vomiting were resolving. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pityriasis, Pruritus, Rash
Clinical narrative: rash worsened following the 2nd injection. Rash then spread all over body and increased in size; Extremely itchy; Diagnosed as possible pityriasis; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient received 2nd dose of BNT162B2 (lot number: EL3249), via an unspecified route of administration in left arm on 20Jan2021 13:45 at single dose for covid-19 immunisation. Medical history known allergies: eggs, shellfish, peanuts. Concomitant medication included desogestrel, ethinylestradiol (APRI). The patient previously received 1st dose of BNT162B2 (lot number: EL0140) in left arm on 30Dec2020 for COVID-19 immunization and experienced rash/mainly on stomach two days after the 1st injection. On an unspecified date of Jan2021, the rash worsened following the 2nd injection. Rash then spread all over body and increased in size. Extremely itchy. Diagnosed as possible pityriasis.  Treatment steroid cream received for the adverse events. The outcome of events was not recovered. This case was reported as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse events result in doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nasopharyngitis
Clinical narrative: Cold; Shivering; Fatigue; This is a spontaneous report from a non-contactable other health professional (patient). A 48-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 19:00 at left arm, at single dose for covid-19 immunization.  Medical history included autoimmune disorder, spinal stenosis, pre-Diabetic. Known allergies was yes. The patient's concomitant medications were not reported. No other medications in two weeks. The patient experienced shivering 8 hrs later at 20Jan2021 03:00 and fatigue immediately after 1 hr of vaccine at 19Jan2021 20:00 and 3 days later cold and fatigue on 22Jan2021. No treatment was received for all events. The outcome o the events was recovered in Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Heart rate, Heart rate increased, Lethargy
Clinical narrative: Increased heart rate; slight lightheaded; headache; sore arm and neck; sore arm and neck; extreme lethargy; This is a spontaneous report from a contactable other-healthcare professional (patient). A 31-year-old female patient (not pregnancy) received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine, lot number: EL9263), via an unspecified route of administration at site of left arm at 15:00 on 22Jan2021 at single dose for covid-19 immunization. Medical history included bursitis, chronic migraines, high blood pressure and fibromyalgia. Concomitant medication included methocarbamol, colecalciferol (VITAMIN D), loratadine and omeprazole, all received in two weeks of vaccination. The patient experienced increased heart rate, slight lightheaded, headache, sore arm and neck, extreme lethargy at 15:30 on 22Jan2021. No other vaccine received in four weeks. Adverse reactions did not result any serious consequences. No treatment received for adverse event. No Covid prior vaccination. No Covid tested post vaccination. Not known allergies. The outcome of events was recovering.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Increased heart rate; slight lightheaded; headache; sore arm and neck; sore arm and neck; extreme lethargy; This is a spontaneous report from a contactable other-healthcare professional (patient). A 31-year-old female patient (not pregnancy) received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine, lot number: EL9263), via an unspecified route of administration at site of left arm at 15:00 on 22Jan2021 at single dose for covid-19 immunization. Medical history included bursitis, chronic migraines, high blood pressure and fibromyalgia. Concomitant medication included methocarbamol, colecalciferol (VITAMIN D), loratadine and omeprazole, all received in two weeks of vaccination. The patient experienced increased heart rate, slight lightheaded, headache, sore arm and neck, extreme lethargy at 15:30 on 22Jan2021. No other vaccine received in four weeks. Adverse reactions did not result any serious consequences. No treatment received for adverse event. No Covid prior vaccination. No Covid tested post vaccination. Not known allergies. The outcome of events was recovering.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dyspnoea, Pyrexia, Rash
Clinical narrative: fever; chills; weakness; rash all over the body; sob; This is a spontaneous report from a contactable nurse (patient).  A 45-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in arm left on 04Jan2021 08:45 at single dose for COVID-19 immunization. The patient was not pregnant at time of vaccination. Medical history included asthma, obesity.  Concomitant medication included ascorbic acid (VITAMIN C), colecalciferol (VITAMIN D), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), macrogol 3350 (MIRALAX), montelukast sodium (SINGULAIR).  The patient previously took cefalexin (KEFLEX) and experienced Known allergies: Keflex. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 01:30 PM Intramuscular in right arm for COVID-19 immunization. The patient experienced fever, chills, weakness, rash all over the body, sob all on 04Jan2021 12:00 with outcome of recovered in Jan2021.  No treatment was received. Information on the Batch/Lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Injection site swelling, Lymphadenopathy, Pain, Rash
Clinical narrative: Rash within an hour on neck, chest, wrists, knees, ankles.; Significantly swollen lymph node at base of neck and subclavicular lymph node on side of injection within 2 days.; Body aches; diarrhea; Swelling over anterior and posterior deltoid above site of injection, swelling across clavicle on side of injection within 3-4 days after injection; Swelling over anterior and posterior deltoid above site of injection, swelling across clavicle on side of injection within 3-4 days after injection; This is a spontaneous report from a non-contactable nurse (patient). A 50-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EK5730), via an unspecified route of administration started on 18Dec2020 18:15 at a single dose in left arm (as reported) for COVID-19 immunization. Medical history included chronic autoimmune inflammatory disorder, autoimmune hypothyroid, polycystic ovarian syndrome (PCOS), Raynauds, asthma, fibromyalgia. There were known allergies: some preservatives, several antibiotics, multiple foods. No Pregnant at the time of vaccination. Concomitant medication included loratadine (CLARITIN), famotidine, ergocalciferol (VIT D), nortriptyline, valaciclovir hydrochloride (VALTREX), received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Dec2020 19:00, the patient experienced rash within an hour on neck, chest, wrists, knees, ankles. significantly swollen lymph node at base of neck and subclavicular lymph node on side of injection within 2 days. body aches, diarrhea x 1 day. swelling over anterior and posterior deltoid above site of injection, swelling across clavicle on side of injection within 3-4 days after injection. Treatment, including ibuprofen (ADVIL), famotidine, clarithromycin (CLARITIN), heat, was received for adverse events. No COVID tested post vaccination. Since the vaccination, the patient was not tested for COVID-19. This is a non-serious report. The adverse event did not result in 'doctor or other HCP visit or emergency room or urgent care, hospitalization or prolongation, life threatening illness, disability or death or congential anomaly'. The outcome of events was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Body aches like with the flu; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received COVID-19 vaccine (UNSPECIFIED TRADE NAME, lot number: unknown) single dose via unspecified route of administration on an unknown date for COVID-19 vaccination. Medical history and concomitant medications were unknown. On an unknown date, the patient experienced  body aches like with the flu for three days. Treatment for the event was unknown. The clinical outcome of body aches like with the flu was recovered on an unknown date.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Spinal pain
Clinical narrative: Severe pain from base of skull down spine to mid back. Can't turn head or move without pain.; Severe pain from base of skull down spine to mid back. Can't turn head or move without pain.; This is a spontaneous report from a contactable Other Health Professional (patient). A 36-year-old female patient not pregnant received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=BL), intramuscularly in left arm on 21Jan2021 19:15 at single dose for COVID-19 immunization. Facility type vaccine: Hospital. Medical history included Known allergies: Latex, morphine, Possible MS.  Concomitant medication in two weeks included Phentermine, vitamin D NOS (VITAMIN D), Vitamin B12 NOS (VITAMIN B12), probiotics, multivitamin. If other vaccine in four weeks: No. The patient experienced severe pain from base of skull down spine to mid back. can't turn head or move without pain on 22Jan2021 17:00 with outcome of not recovered. If treatment AE: No. If covid prior vaccination: No. If covid tested post vaccination: No.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal discharge
Clinical narrative: After 1st COVID-19 injection started with vaginal discharge spotting; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration in left arm on 14Jan2021 at single dose for covid-19 immunization at doctor's office/urgent care. Medical history included cirrhosis of liver, diabetes, there was no known drug allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not underwent for COVID-19 test. Concomitant medication included oxycodone in two weeks. There was no other vaccine in four weeks.  After 1st covid-19 injection the patient started with vaginal discharge spotting on 15Jan2021 16:00. The event resulted in doctor or other healthcare professional office/clinic visit. There was no treatment for the event. The outcome of the event was not resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Lymphadenopathy
Clinical narrative: Painful left axillary lymphadenopathy (1.5 x 2 inch); Fever; Chills; Sweats; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable physician (patient). A 32-year-old female patient received second dose of bnt162b2 (Solution for injection, lot number: EL1283), intramuscularly at Left arm on 22Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included subclinical hypothyroidism and allergies to penicillin from an unknown date. The patient is not pregnant. Concomitant medication included levothyroxine. The patient previously took first dose of bnt162b2 on 02Jan2021 09:00 AM at 32-year-old Intramuscularly at left arm; took BACTRIM and experienced allergies to BACTRIM. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The patient experienced painful left axillary lymphadenopathy (1.5 x 2 inch), fever, chills, sweats, body aches, headache, fatigue from 22Jan2021 10:00 PM. No treatment. The outcome of the events was recovering.   Information on the batch/lot number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Painful left axillary lymphadenopathy (1.5 x 2 inch); Fever; Chills; Sweats; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable physician (patient). A 32-year-old female patient received second dose of bnt162b2 (Solution for injection, lot number: EL1283), intramuscularly at Left arm on 22Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included subclinical hypothyroidism and allergies to penicillin from an unknown date. The patient is not pregnant. Concomitant medication included levothyroxine. The patient previously took first dose of bnt162b2 on 02Jan2021 09:00 AM at 32-year-old Intramuscularly at left arm; took BACTRIM and experienced allergies to BACTRIM. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The patient experienced painful left axillary lymphadenopathy (1.5 x 2 inch), fever, chills, sweats, body aches, headache, fatigue from 22Jan2021 10:00 PM. No treatment. The outcome of the events was recovering.   Information on the batch/lot number has been requested.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Erythema and pruritus at site, about 8cm in diameter; Erythema and pruritus at site, about 8cm in diameter; This is a spontaneous report from a non-contactable physician (patient). A 31-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EJ1686, on 11Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 19Dec2020. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination. The patient had no Covid tested post vaccination. The patient had no Known Allergies. The patient had Erythema and pruritus at site, about 8cm in diameter on 13Jan2021. No treatment was received for the events. The outcome of the events was resolved.  No follow up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Malaise
Clinical narrative: sore arm (briefer than with #1); malaise; fatigue; Pulsing tinnitus, eased off now; bad headache (prexisisting but markedly amplified-still; chills (no fever, 3 days for real, now fading); mild nausea/loss of appetite (largely resolved.); mild nausea/loss of appetite (largely resolved.); This is a spontaneous report from a contactable Physician reported for herself. This 57-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an 09Jan2021 09:00 AM on Arm left at single dose (Lot # EK9231) for covid-19 immunisation. Medical history included Pacemaker, Insomnia, and some preexisting hearing loss, due to effusion. No known allergies. No covid prior vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 16:45 PM on Left arm at single dose (Lot # EH9899) for covid-19 immunisation. Covid test after #1 (December) due to sore arm, chills, aches and malaise. Was negative. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. The patient experienced pulsing tinnitus, eased off now, also sore arm (briefer than with #1), malaise/fatigue (still but better), bad headache (persisting but markedly amplified-still, chills (no fever, 3 days for real, now fading), mild nausea/loss of appetite (largely resolved.) Events all on 10Jan2021 06:00 AM. Lab data included covid test (Nasal Swab) on 22Dec2020: negative. No treatments were received for the events. Outcome of events mild nausea/loss of appetite, malaise, fatigue was recovering.  Outcome of the event chills (no fever, 3 days for real, now fading) was recovered. Outcome of the events was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, SARS-CoV-2 test, Tinnitus
Clinical narrative: sore arm (briefer than with #1); malaise; fatigue; Pulsing tinnitus, eased off now; bad headache (prexisisting but markedly amplified-still; chills (no fever, 3 days for real, now fading); mild nausea/loss of appetite (largely resolved.); mild nausea/loss of appetite (largely resolved.); This is a spontaneous report from a contactable Physician reported for herself. This 57-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an 09Jan2021 09:00 AM on Arm left at single dose (Lot # EK9231) for covid-19 immunisation. Medical history included Pacemaker, Insomnia, and some preexisting hearing loss, due to effusion. No known allergies. No covid prior vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 16:45 PM on Left arm at single dose (Lot # EH9899) for covid-19 immunisation. Covid test after #1 (December) due to sore arm, chills, aches and malaise. Was negative. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. The patient experienced pulsing tinnitus, eased off now, also sore arm (briefer than with #1), malaise/fatigue (still but better), bad headache (persisting but markedly amplified-still, chills (no fever, 3 days for real, now fading), mild nausea/loss of appetite (largely resolved.) Events all on 10Jan2021 06:00 AM. Lab data included covid test (Nasal Swab) on 22Dec2020: negative. No treatments were received for the events. Outcome of events mild nausea/loss of appetite, malaise, fatigue was recovering.  Outcome of the event chills (no fever, 3 days for real, now fading) was recovered. Outcome of the events was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pain in extremity, SARS-CoV-2 test
Clinical narrative: sore arm; Chills; aches; malaise; This is a spontaneous report from a contactable physician reported for herself. A 57-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899), via an unspecified route of administration in left arm on 19Dec2020 16:45 at single dose for COVID-19 immunization.  Medical history included pacemaker, insomnia and some preexisting hearing loss, no known allergies. Concomitant medications included unspecified medication received in two weeks. The patient was no pregnant. There was no other vaccine received at the same date of the product and in four weeks. The patient had no COVID prior vaccination. The patient experienced sore arm on an unspecified date, chills, aches and malaise in Dec2020. COVID test (Nasal Swab) post vaccination on 22Dec2020 due to chills, aches and malaise was negative. No treatment received for the events. The outcome of the events was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Night sweats
Clinical narrative: 40 hours after receiving vaccine, awoke with night sweats.  Felt find otherwise. Went back to sleep and fine in morning.; This is a spontaneous report from a non-contactable consumer. This 67-year-old male consumer (patient) received BNT162B2 (lot number=EL3249) on 21Jan2021 11:30 AM at single dose on Left arm for covid-19 immunization. Medical history was hypertension, chronic atrial fib. Known allergies to contrast media (hives), possibly penicillin (rash as child). No other vaccine in four weeks. 40 hours after receiving vaccine, awoke with night sweats on 23Jan2021 03:00 AM. Felt find otherwise. Went back to sleep and fine in morning. No treatment. Outcome of the event was recovered. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Second dose, massive diarrhea; severe fatigue; chills; diaphoretic; neck pain.; headache; This is a spontaneous report from a contactable Nurse (patient). A 50-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL3248) via an unspecified route of administration on 18Jan2021 at single dose in left arm for COVID-19 immunisation. He received the first dose (EL 3248) at age if 50-year-old on 28Dec2020 10:00 AM Intramuscular in Left arm for COVID-19 immunisation, and after first dose experienced nausea wanting to vomit, massive diarrhea, severe fatigue, with chills and diaphoresis, and bloody stool-diarrhea. Medical history included hypertension. There was no known allergies. Concomitant medication included acetaminophen. After the second dose, on 20Jan2021 10:00 PM the patient had massive diarrhea, severe fatigue, chills, diaphoretic, headache and neck pain. No treatment received for events. Events outcome was recovering.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Second dose, massive diarrhea; severe fatigue; chills; diaphoretic; neck pain.; headache; This is a spontaneous report from a contactable Nurse (patient). A 50-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL3248) via an unspecified route of administration on 18Jan2021 at single dose in left arm for COVID-19 immunisation. He received the first dose (EL 3248) at age if 50-year-old on 28Dec2020 10:00 AM Intramuscular in Left arm for COVID-19 immunisation, and after first dose experienced nausea wanting to vomit, massive diarrhea, severe fatigue, with chills and diaphoresis, and bloody stool-diarrhea. Medical history included hypertension. There was no known allergies. Concomitant medication included acetaminophen. After the second dose, on 20Jan2021 10:00 PM the patient had massive diarrhea, severe fatigue, chills, diaphoretic, headache and neck pain. No treatment received for events. Events outcome was recovering.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at injection site from first dose; This is a spontaneous report from a contactable Nurse (patient).   A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot # either EJ7685 or EJ1685) at single dose at right deltoid on 30Dec2020 for Covid-19 immunisation.  Medical history included gluten sensitivity and developed a rash when she ate gluten. The patient's concomitant medications were not reported.  The patient experienced pain at injection site from 1st dose on 31Dec2020. The outcome of event was recovered on 02Jan2021.   Information about Batch/Lot number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Inappropriate schedule of product administration, Pain
Clinical narrative: FEVER; chills; aches and pain all over; Tiredness; received second dose on 16Jan2021, first dose on 31Dec2020; This is a spontaneous report received from a non-contactable other healthcare professional. A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in the right arm, on 16Jan2021 08:30, at single dose, for COVID-19 immunization. The patient has known allergies to latex, bananas and adhesive. The patient was not pregnant at the time of vaccination. There were no concomitant medications (no other medications in two weeks). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in the right arm, on 31Dec2020 10:30, for COVID-19 immunization. The patient did not have other vaccines in four weeks. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient experienced fever, chills, aches and pain all over and tiredness on 16Jan2021 22:15. Treatment for the events was not given. The outcome of the events was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER; chills; aches and pain all over; Tiredness; received second dose on 16Jan2021, first dose on 31Dec2020; This is a spontaneous report received from a non-contactable other healthcare professional. A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in the right arm, on 16Jan2021 08:30, at single dose, for COVID-19 immunization. The patient has known allergies to latex, bananas and adhesive. The patient was not pregnant at the time of vaccination. There were no concomitant medications (no other medications in two weeks). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in the right arm, on 31Dec2020 10:30, for COVID-19 immunization. The patient did not have other vaccines in four weeks. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient experienced fever, chills, aches and pain all over and tiredness on 16Jan2021 22:15. Treatment for the events was not given. The outcome of the events was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Dizziness, Fatigue
Clinical narrative: Fever up to 102.5; nausea; dizziness; muscle aches; joint aches; headache; fatigue; weakness; heart rate racing; injection site pain; This is a spontaneous report from a non-contactable consumer (patient herself). A 47-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN5318), via an unspecified route of administration (left arm), on 21Jan2021 16:30, at single dose, for covid-19 immunization. The patient has no medical history and has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever up to 102.5, nausea, dizziness, muscle aches, joint aches, headache, fatigue, weakness, heart rate racing, and injection site pain - all on 22Jan2021 02:00. No treatment was received for the events. The patient had not recovered from the events at the time of the report. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Myalgia, Nausea
Clinical narrative: Fever up to 102.5; nausea; dizziness; muscle aches; joint aches; headache; fatigue; weakness; heart rate racing; injection site pain; This is a spontaneous report from a non-contactable consumer (patient herself). A 47-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN5318), via an unspecified route of administration (left arm), on 21Jan2021 16:30, at single dose, for covid-19 immunization. The patient has no medical history and has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever up to 102.5, nausea, dizziness, muscle aches, joint aches, headache, fatigue, weakness, heart rate racing, and injection site pain - all on 22Jan2021 02:00. No treatment was received for the events. The patient had not recovered from the events at the time of the report. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Fever up to 102.5; nausea; dizziness; muscle aches; joint aches; headache; fatigue; weakness; heart rate racing; injection site pain; This is a spontaneous report from a non-contactable consumer (patient herself). A 47-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN5318), via an unspecified route of administration (left arm), on 21Jan2021 16:30, at single dose, for covid-19 immunization. The patient has no medical history and has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever up to 102.5, nausea, dizziness, muscle aches, joint aches, headache, fatigue, weakness, heart rate racing, and injection site pain - all on 22Jan2021 02:00. No treatment was received for the events. The patient had not recovered from the events at the time of the report. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear discomfort, Pain, Vomiting
Clinical narrative: Vomiting about 17 hours after shot; pressure in ears; aches; chills; This is a spontaneous report from a contactable other hcp reporting for herself. A 51-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration on the left arm on 23Jan2021 15:00 at a SINGLE DOSE for covid-19 immunisation.  Medical history included vertigo from an unknown date and unknown if ongoing, food intolerance to raw eggs, red dye and bag lettuce from an unknown date and unknown if ongoing.  Concomitant medication included ibuprofen (ADVIL [IBUPROFEN]) and paracetamol (TYLENOL). The patient previously had the first dose of the vaccine on 06Jan2021 (lot number: EK5730). On 24Jan2021 09:30 AM, the patient experienced vomiting about 17 hours after shot. Also, pressure in ears and like many others aches and chills. No treatment was received for the events. The outcome of the event was recovering.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Migraine, Trigeminal neuralgia
Clinical narrative: Complex Migraine and triggered trigeminal neuralgia event.; Complex Migraine and triggered trigeminal neuralgia event.; Complex Migraine and triggered trigeminal neuralgia event.; This is a spontaneous report from a contactable other healthcare professional. A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: el8982; expiry date: unknown) intramuscular in the right arm, on 22Jan2021 at 11:15, at a single dose, for COVID-19 immunisation. Medical history included ongoing trigeminal neuralgia and polycystic ovaries (PCOS). The patient had no known allergies. Concomitant medication included gabapentin. The previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: ek9231) intramuscular in the left arm, on 31Dec2020 at 10:30 AM for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 23Jan2021 at 09:30, the patient experienced complex migraine and triggered trigeminal neuralgia event. The patient did not receive therapy for the events. Outcome of the events was recovered. The patient has not been tested for COVID-19 since vaccination.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Pruritus, Swelling
Clinical narrative: extremely tiredness; Huge (8"X6") area of swollen red hot area; Huge (8"X6") area of swollen red hot area; Headache; itching; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on 16Jan2021 12:00 at a single dose for COVID-19 immunization. Medical history included diabetic. Concomitant medication was not reported. Patient had no known allergies, was not pregnant and did not have COVID prior to vaccination. On 21Jan2021, the patient reported extreme tiredness, huge (8"x6") area of swollen red hot area, headache and itching. No treatment was received for the events. Patient has not been tested for COVID post-vaccination. Outcome of the events was not recovered.    Information on the lot/batch number has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Malaise, Nausea, Tinnitus
Clinical narrative: left ear ringing; bad headache; nauseous; no energy; I don't feel well; This is a spontaneous report from a contactable other healthcare professional (patient). A 63-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: Elo142), via an unspecified route of administration into the left arm on 14Jan2021 14:30 at a single dose for covid-19 immunisation. Medical history was reported as none. Patient was not pregnant. Concomitant medication included calcium (CALCIUM), vitamin d3 (VITAMIN D3) and monascus purpureus (RED YEAST RICE). On 14Jan2021, patient experienced bad headache, was nauseous, had no energy and was not feeling well. On 15Jan2021, patient also experienced left ear ringing. The patient received no treatment for the events reported. Outcome of events was recovering.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement, Cold sweat, Diarrhoea, Fatigue
Clinical narrative: Got a bumpy itchy rash on both legs which is still present; sweating; arm began to hurt then throb and go numb a bit; arm began to hurt then throb and go numb a bit; The patient was cold; clammy; the first blood pressure was 90 over something/second blood pressure was 70 over 40 something; diarrhea; tired; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: 3247), via an unspecified route of administration in the left arm on 18Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history was none. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 18Jan2021 10:10, the patient's arm began to hurt then throb and go numb a bit. On 18Jan2021 10:15, the patient started sweating. She stood up to try and feel better. The patient's husband called the nurse over and they called the paramedics because they said the patient was cold, clammy, and still sweating. The patient sat down again and they put leads on me to check her heart rate, blood pressure (BP), and oxygen on 18Jan2021. Her heart rate and oxygen were fine but the first BP was 90 over something. A few minutes later, she closed her eyes and could have fallen asleep right there. Her second BP was 70 over 40 something. She opened up her eyes and tried to stand up again. After a few more minutes, her BP came up and was OK. They refused an ambulance and went home. She had diarrhea at home on 18Jan2021. She ate, walked and felt better. She just experienced the normal tired and hurt arm in the afternoon on 18Jan2021. She rested the balance of the day. On Wednesday (20Jan2021), she got a bumpy itchy rash on both legs which is still present but with cream, it was OK. No treatment was received for the adverse events. Outcome of the "the first blood pressure was 90 over something/second blood pressure was 70 over 40 something" was recovered on 18Jan2021 and of the remaining events was recovered on Jan2021.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Heart rate, Hyperhidrosis, Hypoaesthesia, Oxygen saturation
Clinical narrative: Got a bumpy itchy rash on both legs which is still present; sweating; arm began to hurt then throb and go numb a bit; arm began to hurt then throb and go numb a bit; The patient was cold; clammy; the first blood pressure was 90 over something/second blood pressure was 70 over 40 something; diarrhea; tired; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: 3247), via an unspecified route of administration in the left arm on 18Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history was none. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 18Jan2021 10:10, the patient's arm began to hurt then throb and go numb a bit. On 18Jan2021 10:15, the patient started sweating. She stood up to try and feel better. The patient's husband called the nurse over and they called the paramedics because they said the patient was cold, clammy, and still sweating. The patient sat down again and they put leads on me to check her heart rate, blood pressure (BP), and oxygen on 18Jan2021. Her heart rate and oxygen were fine but the first BP was 90 over something. A few minutes later, she closed her eyes and could have fallen asleep right there. Her second BP was 70 over 40 something. She opened up her eyes and tried to stand up again. After a few more minutes, her BP came up and was OK. They refused an ambulance and went home. She had diarrhea at home on 18Jan2021. She ate, walked and felt better. She just experienced the normal tired and hurt arm in the afternoon on 18Jan2021. She rested the balance of the day. On Wednesday (20Jan2021), she got a bumpy itchy rash on both legs which is still present but with cream, it was OK. No treatment was received for the adverse events. Outcome of the "the first blood pressure was 90 over something/second blood pressure was 70 over 40 something" was recovered on 18Jan2021 and of the remaining events was recovered on Jan2021.